Guerbet - Assemblée Générale des actionnaires du 29 mai 2020
Proxinvest note que le conseil d’administration est toujours composé d’une majorité de membres non libres de conflits d’intérêts potentiels avec un taux d’indépendance de 30%. Par conséquent, cela ne nous permet pas d’approuver le renouvellement de Mark Fouquet, membre de la famille Guerbet, d’autant plus que cette famille est en sur représentation au conseil (résolution 17). Par ailleurs, la durée de mandat de 6 ans ne respecte pas les recommandations de Proxinvest, l’ECGS, l’AFG et le Code AFEP-MEDEF.
Tout comme l’année dernière, Proxinvest remarque que les politiques de rémunération des dirigeants manquent d’information, ce qui sera sanctionnée par une recommandation négative aux résolutions 6, 8, 9, 10 et 13.
Guerbet is a French pharmaceutical group that develops, markets, and provides maintenance services for medical equipment and devices destined for diagnostic and interventional imaging. Co.'s portfolio comprises media solutions covering MRI, X-rays and products devoted to International Radiology and Theranostics and medical devices. Co. organizes its operation by product family covering Magnetic Resonance Imaging (MRI), X-rays (XR) and Interventional Radiology and Theranostics (IRT). The MRI family includes Dotarem® and Artirem®; Co.'s X-ray product family includes Xenetix®, Optiray®/Optiject®, Oxilan®, and Telebrix®; and the IRT product family has Lipiodol®, Bleu Patente V and Hexabrix®.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.